A detailed history of Advisors Asset Management, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 151,260 shares of JNJ stock, worth $23.5 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
151,260
Previous 144,694 4.54%
Holding current value
$23.5 Million
Previous $21.1 Million 15.91%
% of portfolio
0.46%
Previous 0.42%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$145.48 - $167.38 $955,221 - $1.1 Million
6,566 Added 4.54%
151,260 $24.5 Million
Q2 2024

Aug 14, 2024

BUY
$144.38 - $157.78 $3.2 Million - $3.5 Million
22,194 Added 18.12%
144,694 $21.1 Million
Q1 2024

May 14, 2024

BUY
$155.22 - $162.74 $3.46 Million - $3.63 Million
22,276 Added 22.23%
122,500 $19.4 Million
Q4 2023

Feb 14, 2024

BUY
$145.6 - $158.88 $2.46 Million - $2.69 Million
16,913 Added 20.3%
100,224 $15.7 Million
Q2 2023

Aug 14, 2023

BUY
$154.35 - $166.11 $1.85 Million - $1.99 Million
11,977 Added 16.79%
83,311 $13.8 Million
Q1 2023

May 12, 2023

SELL
$151.05 - $180.26 $1.73 Million - $2.06 Million
-11,451 Reduced 13.83%
71,334 $11.1 Million
Q4 2022

Feb 13, 2023

SELL
$160.2 - $179.79 $2.06 Million - $2.32 Million
-12,889 Reduced 13.47%
82,785 $14.6 Million
Q3 2022

Nov 08, 2022

SELL
$161.33 - $179.52 $1.6 Million - $1.78 Million
-9,932 Reduced 9.4%
95,674 $15.6 Million
Q2 2022

Aug 08, 2022

SELL
$168.19 - $186.01 $3.07 Million - $3.4 Million
-18,275 Reduced 14.75%
105,606 $18.7 Million
Q1 2022

May 17, 2022

SELL
$158.14 - $179.59 $2.42 Million - $2.75 Million
-15,317 Reduced 11.0%
123,881 $22 Million
Q4 2021

Feb 15, 2022

SELL
$155.93 - $173.01 $2.34 Million - $2.6 Million
-15,019 Reduced 9.74%
139,198 $23.8 Million
Q3 2021

Nov 12, 2021

SELL
$161.5 - $179.47 $7.48 Million - $8.31 Million
-46,309 Reduced 23.09%
154,217 $24.9 Million
Q2 2021

Jul 30, 2021

SELL
$159.48 - $171.07 $4.83 Million - $5.19 Million
-30,313 Reduced 13.13%
200,526 $33 Million
Q1 2021

May 07, 2021

SELL
$153.07 - $170.48 $2.28 Million - $2.54 Million
-14,904 Reduced 6.06%
230,839 $37.9 Million
Q4 2020

Feb 12, 2021

SELL
$137.11 - $157.38 $1.52 Million - $1.75 Million
-11,117 Reduced 4.33%
245,743 $38.7 Million
Q3 2020

Nov 16, 2020

BUY
$140.38 - $153.83 $1.53 Million - $1.68 Million
10,915 Added 4.44%
256,860 $38.2 Million
Q2 2020

Aug 12, 2020

BUY
$128.81 - $155.51 $690,421 - $833,533
5,360 Added 2.23%
245,945 $34.6 Million
Q1 2020

May 15, 2020

BUY
$111.14 - $153.99 $1.33 Million - $1.85 Million
11,998 Added 5.25%
240,585 $31.5 Million
Q4 2019

Feb 14, 2020

SELL
$127.5 - $146.44 $1.68 Million - $1.93 Million
-13,147 Reduced 5.44%
228,587 $34.5 Million
Q3 2019

Nov 14, 2019

SELL
$126.95 - $142.14 $220,893 - $247,323
-1,740 Reduced 0.71%
241,734 $31.3 Million
Q2 2019

Aug 14, 2019

SELL
$131.15 - $144.24 $1.37 Million - $1.51 Million
-10,480 Reduced 4.13%
243,474 $33.9 Million
Q1 2019

May 15, 2019

SELL
$125.72 - $139.79 $97,307 - $108,197
-774 Reduced 0.3%
253,954 $35.5 Million
Q4 2018

Jan 31, 2019

SELL
$122.84 - $147.84 $410,162 - $493,637
-3,339 Reduced 1.29%
254,728 $32.9 Million
Q3 2018

Nov 15, 2018

BUY
$121.58 - $142.88 $3.17 Million - $3.73 Million
26,092 Added 11.25%
258,067 $35.7 Million
Q2 2018

Aug 22, 2018

BUY
$119.4 - $131.76 $4.65 Million - $5.13 Million
38,948 Added 20.18%
231,975 $28.1 Million
Q2 2018

Aug 15, 2018

SELL
$119.4 - $131.76 $1.76 Million - $1.95 Million
-14,768 Reduced 7.11%
193,027 $28.1 Million
Q1 2018

May 15, 2018

BUY
$125.1 - $148.14 $1.92 Million - $2.28 Million
15,385 Added 8.0%
207,795 $27 Million
Q4 2017

Feb 13, 2018

BUY
$131.22 - $143.62 $1.33 Million - $1.46 Million
10,145 Added 5.57%
192,410 $26.9 Million
Q3 2017

Nov 07, 2017

BUY
$129.47 - $135.38 $23.6 Million - $24.7 Million
182,265
182,265 $23.7 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Advisors Asset Management, Inc. Portfolio

Follow Advisors Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.